Shuangshi Tonglin Capsule Improves Prostate Fibrosis through Nrf2/TGF-β1 Signaling Pathways.
10.1007/s11655-025-3926-6
- Author:
Zi-Qiang WANG
1
;
Peng MAO
2
;
Bao-An WANG
2
;
Qi GUO
3
;
Hang LIU
3
;
Yong YUAN
1
;
Chuan WANG
1
;
Ji-Ping LIU
1
;
Xing-Mei ZHU
1
;
Hao WEI
4
,
5
Author Information
1. School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi Province, 712046, China.
2. Shaanxi Momentum Pharmaceutical Co., Ltd., Xianyang, Shaanxi Province, 712000, China.
3. Urology Department, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi Province, 712000, China.
4. School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi Province, 712046, China. weihao217@
5. com.
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
Shuangshi Tongling Capsules;
nuclear factor erythroid 2-related factor 2/heme oxygenase-1pathway;
prostate fibrosis;
transforming growth factor-β1/Smad pathway
- MeSH:
Male;
NF-E2-Related Factor 2/metabolism*;
Animals;
Drugs, Chinese Herbal/therapeutic use*;
Signal Transduction/drug effects*;
Transforming Growth Factor beta1/metabolism*;
Rats, Sprague-Dawley;
Humans;
Fibrosis;
Prostate/drug effects*;
Cell Proliferation/drug effects*;
Capsules;
Cell Movement/drug effects*;
Oxidative Stress/drug effects*;
Rats
- From:
Chinese journal of integrative medicine
2025;31(6):518-528
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To investigate the effect and mechanism of Shuangshi Tonglin Capsules (SSTL) in the treatment of prostate fibrosis (PF).
METHODS:Human prostate stromal cells (WPMY-1) were used for in vitro experiments to establish PF cell models induced with estradiol (E2). The cell proliferation, migration and clonogenic capacity were determined by cell counting kit-8, scratch assay, and crystal violet staining, respectively. Sprague-Dawley rats were used for in vivo experiments. The changes in histomorphology and organ index of rat prostate by SSTL were determined. Pathologic changes and collagen deposition changes in rat prostate were observed by haematoxylin and eosin (HE) and Masson staining. Enzyme-linked immunosorbent assay kits were used to determine changes in rat PF markers fibroblast growth factor-23 (FGF-23), E2 and prostate specific antigen (PSA). Mechanistically, changes in oxidative stress indicators by SSTL were determined in WPMY-1 cells and PF rats. Then the expressions of nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) and transforming growth factor-β1 (TGF-β1)/Smad pathway-related proteins as well as Nrf2 and TGF-β1 mRNA were further detected by Western blot or quantitative real-time polymerase chain reaction both in vivo and in vitro.
RESULTS:In the efficacy study, SSTL significantly reduced the proliferation, migration, and clonogenic ability of cells, improved the morphology of the glandular tissue, significantly reduced the prostate index, reduced glandular fibrous tissue and collagen deposition, and resulted in a significant decrease in the levels of FGF-23, E2 and PSA (P<0.01 or P<0.05). In the mechanistic study, SSTL ameliorated oxidative stress by significantly increasing superoxide dismutase and glutathione peroxidase levels and decreasing malondialdehyde level in WPMY-1 cells and rats (P<0.01 or P<0.05). SSTL significantly elevated the expressions of Nrf2, HO-1, NAD(P)H quinone oxidoreductase 1 (NQO-1), and Smad7 proteins in both cells and rats, and significantly decreased the expressions of TGF-β1, collagen I, α-smooth muscle actin and Smad4 proteins (P<0.01 or P<0.05). SSTL also elevated the content of Nrf2 mRNA and decreased the content of TGF-β1 mRNA in cells and rats (P<0.01 or P<0.05). The Nrf2 inhibitor ML385 was added in in vitro experiments to further validate the pathway relevance.
CONCLUSION:SSTL was effective in improving PF in vivo and in vitro, and its mechanism of action may function through the Nrf2/TGF-β1 signaling pathway.
